Amifampridine
- Generic Name
- Amifampridine
- Brand Names
- Firdapse, Ruzurgi, Firdapse (previously Zenas), Amifampridine SERB
- Drug Type
- Small Molecule
- Chemical Formula
- C5H7N3
- CAS Number
- 54-96-6
- Unique Ingredient Identifier
- RU4S6E2G0J
- Background
Amifampridine, or 3,4-diaminopyridine (3,4-DAP), is a quaternary ammonium compound that blocks presynaptic potassium channels, and subsequently prolongs the action potential and increases presynaptic calcium concentrations . It was first discovered in Scotland in the 1970s and its clinical effectiveness for neuromuscular disorders, including Lambert–Eaton my...
- Indication
用于治疗6岁及以上的成人和儿童患者的一种罕见病自身免疫疾病兰伯特-伊顿（Lambert Eaton）肌无力综合征（LEMS）。LEMS最常见的表现是肌无力，容易疲劳，可导致行走及爬楼梯困难。
- Associated Conditions
- Lambert Eaton Myasthenic Syndrome (LEMS)
- Associated Therapies
- -
Is Catalysts Pharmaceuticals, Inc. (CPRX) the Best Performing Biotech Stock in 2024?
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) ranks 9th among top-performing biotech stocks in 2024, with Q3 2024 revenues of $128.7M, a 25.3% YoY increase. CPRX's success is driven by products like Firdapse and Agamree, with updated full-year revenue guidance of $475–$485M. Despite its performance, AI stocks are considered more promising for higher returns.
Madrigal, Corcept, Catalyst Larimar and Theravance: Zacks Industry Outlook
Trump's reelection may boost biotech innovation and M&A activity, potentially repealing the Inflation Reduction Act. Key roles in federal health agencies will influence drug pricing reforms. The Zacks Medical-Drugs industry, despite headwinds, shows promising trends with innovation in diabetes/obesity, inflammation, and neuroscience. Small drugmakers rely on collaboration partners and R&D funding, with notable stocks including Corcept Therapeutics, Madrigal Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, and Larimar Therapeutics.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath